Learn More
Medchemexpress LLC Rufinamide-d2 | 1129491-38-8 | C10H6D2F2N4O | 1 MG

Supplier: Medchemexpress LLC HYA0042S1MG
Rufinamide-d2 (CGP 33101-d2) is a deuterium-labeled Rufinamide, an orally active antiepileptic compound. It inhibits Na+ current activation and neuronal hyperexcitability, exhibiting anticonvulsant effects. This compound is utilized in the study of Lennox-Gastaut syndrome, with its deuteration influencing pharmacokinetic and metabolic profiles.
- Inhibits Na+ current activation
- Inhibits neuronal hyperexcitability
- Provides anticonvulsant effects
- Used in the study of Lennox-Gastaut syndrome
- Deuterium-labeled for tracer applications
- Influences pharmacokinetic and metabolic profiles
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.